Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.4157
-0.0350 (-7.77%)
At close: Mar 28, 2025, 4:00 PM
0.4300
+0.0143 (3.44%)
After-hours: Mar 28, 2025, 7:20 PM EDT

Cognition Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Selling, General & Admin
12.2913.5313.2310.034.52
Upgrade
Research & Development
41.6837.230.3218.5712.89
Upgrade
Operating Expenses
53.9750.7243.5528.617.41
Upgrade
Operating Income
-53.97-50.72-43.55-28.6-17.41
Upgrade
Interest Expense
-0.03-0.03-0.03-0.89-1.75
Upgrade
Currency Exchange Gain (Loss)
-0.2----
Upgrade
Other Non Operating Income (Expenses)
20.2224.9622.1817.3311.45
Upgrade
EBT Excluding Unusual Items
-33.97-25.79-21.4-12.16-7.71
Upgrade
Other Unusual Items
---0.44-0.13
Upgrade
Pretax Income
-33.97-25.79-21.4-11.72-7.84
Upgrade
Net Income
-33.97-25.79-21.4-11.72-7.84
Upgrade
Preferred Dividends & Other Adjustments
---4.534.23
Upgrade
Net Income to Common
-33.97-25.79-21.4-16.25-12.07
Upgrade
Shares Outstanding (Basic)
40302451
Upgrade
Shares Outstanding (Diluted)
40302451
Upgrade
Shares Change (YoY)
32.31%27.03%355.42%921.60%8.18%
Upgrade
EPS (Basic)
-0.86-0.86-0.91-3.13-23.76
Upgrade
EPS (Diluted)
-0.86-0.86-0.91-3.13-23.76
Upgrade
Free Cash Flow
-28.48-16.17-18.7-3.66-3.44
Upgrade
Free Cash Flow Per Share
-0.72-0.54-0.79-0.70-6.78
Upgrade
EBITDA
-53.86-50.63-43.47-28.51-17.31
Upgrade
D&A For EBITDA
0.110.10.080.090.1
Upgrade
EBIT
-53.97-50.72-43.55-28.6-17.41
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q